Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

PubMed Links for Books (Select 2263760)

1.

Emerging drugs for active tuberculosis.

Ginsberg AM.

Semin Respir Crit Care Med. 2008 Oct;29(5):552-9. doi: 10.1055/s-0028-1085706. Epub 2008 Sep 22. Review.

PMID:
18810688
2.

Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory perspective.

Sacks LV, Behrman RE.

Tuberculosis (Edinb). 2008 Aug;88 Suppl 1:S93-100. doi: 10.1016/S1472-9792(08)70040-4. Review.

PMID:
18762157
3.

Comprehensive treatment of extensively drug-resistant tuberculosis.

Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, Fitzmaurice GM, Alcantara Viru FA, Appleton SC, Bayona JN, Bonilla CA, Chalco K, Choi S, Franke MF, Fraser HS, Guerra D, Hurtado RM, Jazayeri D, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Sloutsky A, Becerra MC.

N Engl J Med. 2008 Aug 7;359(6):563-74. doi: 10.1056/NEJMoa0800106.

4.

Pharmaceutical policy in China.

Sun Q, Santoro MA, Meng Q, Liu C, Eggleston K.

Health Aff (Millwood). 2008 Jul-Aug;27(4):1042-50. doi: 10.1377/hlthaff.27.4.1042.

5.

Risk factors for delay in the diagnosis and treatment of tuberculosis at a referral hospital in Rwanda.

Lorent N, Mugwaneza P, Mugabekazi J, Gasana M, Van Bastelaere S, Clerinx J, Van den Ende J.

Int J Tuberc Lung Dis. 2008 Apr;12(4):392-6.

PMID:
18371264
6.

Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance.

Gelmanova IY, Keshavjee S, Golubchikova VT, Berezina VI, Strelis AK, Yanova GV, Atwood S, Murray M.

Bull World Health Organ. 2007 Sep;85(9):703-11.

7.

Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

Mitnick CD, Castro KG, Harrington M, Sacks LV, Burman W.

PLoS Med. 2007 Nov 6;4(11):e292. No abstract available.

8.

Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study.

Basu S, Andrews JR, Poolman EM, Gandhi NR, Shah NS, Moll A, Moodley P, Galvani AP, Friedland GH.

Lancet. 2007 Oct 27;370(9597):1500-7.

9.

A web-based laboratory information system to improve quality of care of tuberculosis patients in Peru: functional requirements, implementation and usage statistics.

Blaya JA, Shin SS, Yagui MJ, Yale G, Suarez CZ, Asencios LL, Cegielski JP, Fraser HS.

BMC Med Inform Decis Mak. 2007 Oct 28;7:33.

10.

Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease.

Keshavjee S, Gelmanova IY, Pasechnikov AD, Mishustin SP, Andreev YG, Yedilbayev A, Furin JJ, Mukherjee JS, Rich ML, Nardell EA, Farmer PE, Kim JY, Shin SS.

Ann N Y Acad Sci. 2008;1136:1-11. Epub 2007 Oct 22.

PMID:
17954675
11.

Barriers to reaching the targets for tuberculosis control: multidrug-resistant tuberculosis.

Blöndal K.

Bull World Health Organ. 2007 May;85(5):387-90; discussion 391-4.

12.

Roles of laboratories and laboratory systems in effective tuberculosis programmes.

Ridderhof JC, van Deun A, Kam KM, Narayanan PR, Aziz MA.

Bull World Health Organ. 2007 May;85(5):354-9.

13.

Planning to improve global health: the next decade of tuberculosis control.

Maher D, Dye C, Floyd K, Pantoja A, Lonnroth K, Reid A, Nathanson E, Pennas T, Fruth U, Cunningham J, Ignatius H, Raviglione MC, Koek I, Espinal M.

Bull World Health Organ. 2007 May;85(5):341-7.

14.

HIV infection and multidrug-resistant tuberculosis: the perfect storm.

Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Castro KG, Weyer K.

J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107. Review.

15.
16.

Extensively drug-resistant tuberculosis: are we learning from history or repeating it?

Dukes Hamilton C, Sterling TR, Blumberg HM, Leonard M, McAuley J, Schlossberg D, Stout J, Huitt G.

Clin Infect Dis. 2007 Aug 1;45(3):338-42. Epub 2007 Jun 22.

17.

Non-physician clinicians in 47 sub-Saharan African countries.

Mullan F, Frehywot S.

Lancet. 2007 Dec 22;370(9605):2158-63.

PMID:
17574662
18.

Scaling up health workforces in response to critical shortages.

Hanvoravongchai P.

Lancet. 2007 Dec 22;370(9605):2080-1. No abstract available.

PMID:
17574661
19.

Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.

Cox HS, Niemann S, Ismailov G, Doshetov D, Orozco JD, Blok L, Rüsch-Gerdes S, Kebede Y.

Clin Infect Dis. 2007 Jun 1;44(11):1421-7. Epub 2007 Apr 24.

20.

Expanding culture and drug susceptibility testing capacity in tuberculosis diagnostic services: the new challenge.

Aziz M, Ryszewska K, Blanc L, Vincent V, Getahun H, Wright A, Nunn P, Raviglione M.

Int J Tuberc Lung Dis. 2007 Mar;11(3):247-50. No abstract available.

PMID:
17352087
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk